Top Markets
Coin of the day
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Classement en actions #5575
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Prix de l'action
$36.98
Dernière synchronisation: 2026-08-26
Capitalisation boursière
$2.58B
Changement (1 jour)
-0.67%
Changement (1 an)
55.51%
Pays
NL
Échange Pharvaris N.V. (PHVS)

Catégorie

Historique des divisions d’actions pour Pharvaris N.V. (PHVS)
L’action Pharvaris N.V. (symbole : PHVS) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 27, 2026.
Une action PHVS achetée avant le Aug 27, 2026 équivaudrait aujourd’hui à 0 actions PHVS.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH